Skip to main content
OpenTrials

Clinical trial condition

Carcinoma, Hepatocellular

Explore clinical trials studying Carcinoma, Hepatocellular. Study availability and eligibility vary by location and protocol.

2,099 public trials 529 recruiting studies
Refine in advanced search Browse all conditions

Carcinoma, Hepatocellular trial results

Active, Not Recruiting

QUILT-3.055: A Study of Combination Immunotherapies in Patients Who Have Previously Received Treatment With Immune Checkpoint Inhibitors

NCT03228667

Conditions
Adenocarcinoma, Bronchial Neoplasms, Carcinoma, +79 more
Locations
  • Alaska Clinical Research Center Anchorage, Alaska, United States
  • Genesis Cancer Center Hot Springs, Arkansas, United States
  • Chan Soon-Shiong Institute for Medicine El Segundo, California, United States
  • MemorialCare Health System Fountain Valley, California, United States
View all 35 locations
View Trial Details
Active, Not Recruiting

Study of DECOY20 With or Without Tislelizumab in Patients With Advanced Solid Tumors

NCT05651022

Conditions
Adenocarcinoma, Bronchial Neoplasms, CRC (Colorectal Cancer), +31 more
Locations
  • University of Southern California- Norris Cancer Center Los Angeles, California, United States
  • Hoag Memorial Hospital Presbyterian Newport Beach, California, United States
  • Winship Cancer Institute of Emory University Atlanta, Georgia, United States
  • The Barbara Ann Karmanos Cancer Institute Detroit, Michigan, United States
View Trial Details
Active, Not Recruiting

The HistoSonics System for Treatment of Primary and Metastatic Liver Tumors Using Histotripsy (#HOPE4LIVER EU/UK)

NCT04573881

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +10 more
Locations
  • Städtisches Klinikum Braunschweig gGmbH Braunschweig, Germany
  • Universitätsklinikum Magdeburg Klinik für Radiologie und Nuklearmedizin Magdeburg, Germany
  • Istituto Clinico Humanitas - Humanitas Mirasole S.P.A. Milan, Italy
  • Vall d'Hebron Barcelona, Spain
View Trial Details
Active, Not Recruiting

A Study Investigating the Outcomes and Safety of Atezolizumab Under Real-World Conditions in Patients Treated in Routine Clinical Practice

NCT03782207

Conditions
Adenocarcinoma, Bronchial Neoplasms, Carcinoma, +22 more
Locations
  • Hospital Universitario Austral Buenos Aires, Argentina
  • Lucen S.A. Buenos Aires, Argentina
  • Consultorio Privado Korbenfeld CABA, Argentina
  • Hospital Italiano de Buenos Aires Ciudad Autonoma Buenos Aires, Argentina
View all 258 locations
View Trial Details
Active, Not Recruiting

Multi-Center Study of the Effects of Simvastatin on Hepatic Decompensation and Death in Subjects Presenting With High-Risk Compensated Cirrhosis

NCT03654053

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +12 more
Locations
  • San Francisco VA Medical Center, San Francisco, CA San Francisco, California, United States
  • VA Connecticut Healthcare System West Haven Campus, West Haven, CT West Haven, Connecticut, United States
  • Robley Rex VA Medical Center, Louisville, KY Louisville, Kentucky, United States
  • VA Boston Healthcare System Jamaica Plain Campus, Jamaica Plain, MA Boston, Massachusetts, United States
View Trial Details
Active, Not Recruiting

A Study Evaluating Atezolizumab and Bevacizumab, With or Without Tiragolumab, in Participants With Untreated Locally Advanced or Metastatic Hepatocellular Carcinoma (HCC) (IMbrave152)

NCT05904886

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
Locations
  • Genesis Cancer Center Hot Springs, Arkansas, United States
  • UCSF Fresno at Community Cancer Institute Clovis, California, United States
  • City of Hope Cancer Center Duarte, California, United States
  • University of California San Diego Moores Cancer Center La Jolla, California, United States
View all 171 locations
View Trial Details
Active, Not Recruiting

A Study to Evaluate Camrelizumab Plus Rivoceranib (Apatinib) as Adjuvant Therapy in Patients With Hepatocellular Carcinoma (HCC) at High Risk of Recurrence After Curative Resection or Ablation

NCT04639180

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
Locations
  • The First Affiliated Hospital of Chongqing Medical University Chongqing, Chongqing Municipality, China
  • Guangxi Medical University Affiliated Tumor Hospital Nanjin, Guangzhou, China
  • Guizhou Cancer Hospital Guiyang, Guizhou, China
  • Renji Hospital, Shanghai Jiaotong University School of Medicine Shanghai, Shanghai Municipality, China
View Trial Details
Active, Not Recruiting

A Study to Evaluate INCB099280 in Participants With Select Solid Tumors Who Are Immune Checkpoint Inhibitor Naive

NCT05879822

Conditions
Adenocarcinoma, Advanced Solid Tumor, Bronchial Neoplasms, +36 more
Locations
  • Fundacao Pio Xii Hospital de Cancer de Barretos Barretos, Brazil
  • Cionc-Centro Integrado de Oncologia de Curitiba Curitiba, Brazil
  • Hospital Erasto Gaertner - Liga Paranaense de Combate Ao Câncer Curitiba, Brazil
  • Oncosite - Centro de Pesquisa Clinica E Oncologia Ijuí, Brazil
View all 54 locations
View Trial Details

Related conditions